Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Trichomonas vaginalis 20s proteasome catalytic subunits denaturing gel proteomics

ABSTRACT: Sample 7 = top band, sample 8 = middle band, sample 9 = lowest band. Purified tv20S was incubated with 2uM MV151 probe overnight and imaged. The three bands visualized were excised and trypsin digested for proteomics. The data was searched against the T. vaginalis proteome.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Trichomonas Vaginalis (ncbitaxon:5722)

SUBMITTER: Samuel Myers Anthony O'Donoghue

PROVIDER: MSV000092082 | MassIVE | Thu Jun 01 15:51:00 BST 2023

SECONDARY ACCESSION(S): PXD042632

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Identification of Trichomonas vaginalis 5-nitroimidazole resistance targets

Project description:We aimed to delineate mechanisms of T. vaginalis resistance using transcriptome profiling of metronidazole (MTZ)-resistant and sensitive T. vaginalis clinical isolates.

2023-04-30 | GSE227448 | GEO

The transcriptional response of Trichomonas vaginalis to Trichomonas-derived extracellular vehicles

Project description:Trichomonas vaginalis, a common sexually transmitted parasite that colonizes the human urogenital tract, secretes extracellular vesicles (TvEVs) that are taken up by human cells and are speculated to be taken up by parasites as well. While the crosstalk between TvEVs and human cells has led to insight into host:parasite interactions, the role of TvEVs in infection have largely been one-sided, with little known about the effect of TvEV uptake by T. vaginalis. Approximately 11% of infections are found to be co-infections of multiple T. vaginalis strains. Clinical isolates often differ in their adherence to and cytolysis of host cells, underscoring the importance of understanding the effects of TvEV uptake within the parasite population. To address this question our lab observed the effects of EV uptake by T. vaginalis on parasite gene expression. Using RNA-seq, we showed that TvEVs upregulate expression of predicted parasite membrane proteins and identified a novel adherence factor, heteropolysaccharide binding protein (HPB2).

2024-05-28 | GSE253522 | GEO

Recombinant trichomonas vaginalis proteasome native gel digest

Project description:Recombinant proteasome (expressed in S. frugiperda) was loaded to native gel. Gel band was visualized via silver stain and excised for proteomics. MS data was searched against a fasta file including the proteome of S. frugiperda and the cloned T. vaginalis proteins.

2023-05-26 | MSV000092044 | MassIVE

Transcription profiling of Trichomonas vaginalis cultured in the low-iron and high-iron conditions

Project description:Transcriptional changes of Trichomonas vaginalis cultured in the low-iron and high-iron conditions.

2010-07-24 | E-MTAB-126 | biostudies-arrayexpress

Trichomonas vaginalis

Project description:Trichomonas vaginalis Genome sequencing

| PRJNA280779 | ENA

Trichomonas vaginalis

Project description:Trichomonas vaginalis Transcriptome or Gene expression

| PRJNA345042 | ENA

Trichomonas vaginalis

Project description:Trichomonas vaginalis Transcriptome or Gene expression

| PRJNA849385 | ENA

The transcriptional response of prostate cells to Trichomonas vaginalis extracellular vehicles

Project description:The sexually transmitted parasite Trichomonas vaginalis secretes extracellular vesicles (TvEVs) that are internalized by human host cells. The goal of this experiment was to identify the effects of TvEV uptake on host cell gene expression.

2024-10-03 | GSE278360 | GEO

Genome-wide map of H3K4me3 and H3K27Ac in the protozoan parasite Trichomonas vaginalis

Project description:In this study, we investigated genome-wide transcriptional and epigenetic responses of T. vaginalis to histone deacetylase (HDAC) inhibitors.

2017-04-03 | GSE89662 | GEO

20S Proteasome as a Drug Target in Trichomonas vaginalis.

Project description:Trichomoniasis is a sexually transmitted disease with hundreds of millions of annual cases worldwide. Approved treatment options are limited to two related nitro-heterocyclic compounds, yet resistance to these drugs is an increasing concern. New antimicrobials against the causative agent, Trichomonas vaginalis, are urgently needed. We show here that clinically approved anticancer drugs that inhibit the proteasome, a large protease complex with a critical role in degrading intracellular proteins in eukaryotes, have submicromolar activity against the parasite in vitro and on-target activity against the enriched T. vaginalis proteasome in cell-free assays. Proteomic analysis confirmed that the parasite has all seven ? and seven ? subunits of the eukaryotic proteasome although they have only modest sequence identities, ranging from 28 to 52%, relative to the respective human proteasome subunits. A screen of proteasome inhibitors derived from a marine natural product, carmaphycin, revealed one derivative, carmaphycin-17, with greater activity against T. vaginalis than the reference drug metronidazole, the ability to overcome metronidazole resistance, and reduced human cytotoxicity compared to that of the anticancer proteasome inhibitors. The increased selectivity of carmaphycin-17 for T. vaginalis was related to its >5-fold greater potency against the ?1 and ?5 catalytic subunits of the T. vaginalis proteasome than against the human proteasome subunits. In a murine model of vaginal trichomonad infection, proteasome inhibitors eliminated or significantly reduced parasite burden upon topical treatment without any apparent adverse effects. Together, these findings validate the proteasome of T. vaginalis as a therapeutic target for development of a novel class of trichomonacidal agents.

| S-EPMC6811414 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data